June 26, 2020 / 11:28 AM / 12 days ago

BRIEF-Axsome Therapeutics Receives FDA Breakthrough Therapy Designation For AXS-05

June 26 (Reuters) - Axsome Therapeutics Inc:

* AXSOME THERAPEUTICS RECEIVES FDA BREAKTHROUGH THERAPY DESIGNATION FOR AXS-05 FOR THE TREATMENT OF ALZHEIMER’S DISEASE AGITATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below